ClinConnect ClinConnect Logo
Search / Trial NCT05639465

Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children

Launched by UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · Nov 26, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, called "Journey of Hope-C19," is focused on helping children who have experienced emotional distress due to the COVID-19 pandemic and other significant disasters. The study aims to see if a special program can prevent behavioral health issues, such as problems with feelings and relationships, in children from racial and ethnic minority backgrounds living in low-income communities. By providing support and coping skills, the researchers hope to promote better mental health and social connections among these children.

To participate, children need to be in 3rd to 8th grade and should have felt the impact of the pandemic and another major disaster. They also need to show some emotional challenges, as indicated by a questionnaire. It's important that children can communicate in English or Spanish. However, those currently receiving treatment for mental health issues or unable to work in groups cannot join. If eligible, participants can expect to learn valuable skills and receive support in a group setting while contributing to important research that could help other children in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • child experienced the COVID-19 pandemic and an additional large-scale disaster
  • child score is 5 or above on the Strengths and Difficulties Questionnaire
  • child is in 3- 8th grade at enrollment
  • the parent or guardian must complete informed consent and child assent
  • child must speak English or Spanish.
  • Exclusion Criteria:
  • child is currently receiving treatment for a diagnosed mental health condition
  • children who are not able to interact with other students in a group work format, regardless of IEP status

About University Of Illinois At Urbana Champaign

The University of Illinois at Urbana-Champaign is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong commitment to rigorous scientific inquiry, the university conducts clinical trials aimed at improving patient outcomes and understanding complex health challenges. Leveraging its multidisciplinary expertise and state-of-the-art facilities, the university collaborates with healthcare professionals and researchers to explore novel therapeutic interventions and enhance evidence-based practices. Through its clinical trials, the University of Illinois at Urbana-Champaign strives to contribute significantly to the advancement of medical science and public health.

Locations

Houston, Texas, United States

Bradenton, Florida, United States

Panama City, Florida, United States

New Orleans, Louisiana, United States

Dickinson, Texas, United States

West Palm Beach, Florida, United States

New Orleans, Louisiana, United States

La Marque, Texas, United States

Saint Petersburg, Florida, United States

St. Petersburg, Florida, United States

Patients applied

0 patients applied

Trial Officials

Tara Leytham Powell, PhD

Principal Investigator

University of Illinois Urbana Champaign

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials